Letter |
| Mendoza Alvarez LB, Barker R, Nelson C, DiMaggio T, Stone KD, Milner JD, Rosenthal JA, Petroni DH, Glover SC, Lyons JJ, Clinical response to omalizumab in patients with hereditary α-tryptasemia. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2020 Jan;124(1):99-100.e1 | 2020 |
| Navaneethan U, Edminister T, Zhu X, Kommaraju K, Glover S, Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease. Inflammatory bowel diseases, 2017 Apr;23(4):E17 | 2017 |
| Li J, Shouval DS, Doty AL, Snapper SB, Glover SC, Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakin Treatment Suggests Further Mechanism for Mucosal Healing. Journal of clinical immunology, 2017 Feb;37(2):104-107 | 2017 |
Journal Article |
| Osterman MT, VanDussen KL, Gordon IO, Davis EM, Li K, Simpson K, Ciorba M, Glover SC, Abraham B, Guo X, Yee EU, Allard FD, Perrigoue JG, Claggett B, Shen B, Stappenbeck TS, Liu JJ, Epithelial Cell Biomarkers Are Predictive of Response to Biologic Agents in Crohn's Disease. Inflammatory bowel diseases, 2021 Apr 15;27(5):677-685 | 2021 |
| Liu JJ, Sloan ME, Owings AH, Figgins E, Gauthier J, Gharaibeh R, Robinson T, Williams H, Sindel CB, Backus F, Ayyalasomayajula K, Parker A, Senitko M, Abraham GE 3rd, Claggett B, Horwitz BH, Jobin C, Adelman RM, Diamond G, Glover SC, Increased ACE2 Levels and Mortality Risk of Patients With COVID-19 on Proton Pump Inhibitor Therapy. The American journal of gastroenterology, 2021 May 27; | 2021 |
| Konnikova L, Robinson TO, Owings AH, Shirley JF, Davis E, Tang Y, Wall S, Li J, Hasan MH, Gharaibeh RZ, Mendoza Alvarez LB, Ryan LK, Doty A, Chovanec JF, O'Connell MP, Grunes DE, Daley WP, Mayer E, Chang L, Liu J, Snapper SB, Milner JD, Glover SC, Lyons JJ, Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia. The Journal of allergy and clinical immunology, 2021 Apr 15; | 2021 |
| Hamilton MJ, Zhao M, Giannetti MP, Weller E, Hufdhi R, Novak P, Mendoza-Alvarez LB, Hornick J, Lyons JJ, Glover SC, Castells MC, Pozdnyakova O, Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome. The American journal of surgical pathology, 2021 Jul 1;45(7):997-1004 | 2021 |
| Osterman MT, Gordon IO, Davis EM, Ciorba M, Glover SC, Abraham B, Khan F, Guo X, Yee EU, Allard FD, Claggett B, Shen B, Liu JJ, Mucosal Biomarker of Innate Immune Activation Predicts Response to Vedolizumab in Crohn's Disease. Inflammatory bowel diseases, 2020 Sep 18;26(10):1554-1561 | 2020 |
| Moon N, Aryan M, Westerveld D, Nathoo S, Glover S, Kamel AY, Clinical Manifestations of Copper Deficiency: A Case Report and Review of the Literature. Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition, 2020 Oct 9; | 2020 |
| Johnson AN, Harkema JR, Nelson AJ, Dickinson JD, Kalil J, Duryee MJ, Thiele GM, Kumar B, Singh AB, Gaurav R, Glover SC, Tang Y, Romberger DJ, Kielian T, Poole JA, MyD88 regulates a prolonged adaptation response to environmental dust exposure-induced lung disease. Respiratory research, 2020 Apr 22;21(1):97 | 2020 |
| Mendoza Alvarez LB, Liu X, Glover S, Treatment-resistant eosinophilic oesophagitis successfully managed with tofacitinib. BMJ case reports, 2019 Dec 11;12(12) | 2019 |
| Danese S, Sandborn WJ, Colombel JF, Vermeire S, Glover SC, Rimola J, Siegelman J, Jones S, Bornstein JD, Feagan BG, Endoscopic, Radiologic, and Histologic Healing With Vedolizumab in Patients With Active Crohn's Disease. Gastroenterology, 2019 Oct;157(4):1007-1018.e7 | 2019 |
| Chen C, Hartzema AG, Xiao H, Wei YJ, Chaudhry N, Ewelukwa O, Glover SC, Zimmermann EM, Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy. Inflammatory bowel diseases, 2019 Jul 17;25(8):1417-1427 | 2019 |
| Ayoub F, Kamel AY, Ouni A, Chaudhry N, Ader Y, Tan S, Iqbal A, Zimmermann EM, Glover SC, Pre-operative total parenteral nutrition improves post-operative outcomes in a subset of Crohn's disease patients undergoing major abdominal surgery. Gastroenterology report, 2019 Apr;7(2):107-114 | 2019 |
| Schwimmer D, Glover S, Primary Immunodeficiency and the Gut. Gastroenterology clinics of North America, 2019 Jun;48(2):199-220 | 2019 |
| Glover SC, Nouri MZ, Tuna KM, Mendoza Alvarez LB, Ryan LK, Shirley JF, Tang Y, Denslow ND, Alli AA, Lipidomic analysis of urinary exosomes from hereditary α-tryptasemia patients and healthy volunteers. FASEB bioAdvances, 2019 Oct;1(10):624-638 | 2019 |
| Sands BE, Sandborn WJ, Panaccione R, O'Brien CD, Zhang H, Johanns J, Adedokun OJ, Li K, Peyrin-Biroulet L, Van Assche G, Danese S, Targan S, Abreu MT, Hisamatsu T, Szapary P, Marano C, UNIFI Study Group., Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis. The New England journal of medicine, 2019 Sep 26;381(13):1201-1214 | 2019 |
| Li J, Glover SC, Innate Lymphoid Cells in Inflammatory Bowel Disease. Archivum immunologiae et therapiae experimentalis, 2018 Dec;66(6):415-421 | 2018 |
| Ewelukwa O, Perez R, Carter LE, Fernandez A, Glover S, Incorporation of Scribes Into the Inflammatory Bowel Disease Clinic Improves Quality of Care and Physician Productivity. Inflammatory bowel diseases, 2018 Feb 15;24(3):552-557 | 2018 |
| Kamel AY, Ayoub F, Banerjee D, Chaudhry N, Ader Y, Tan S, Zimmermann EM, Glover SC, Iqbal A, Effects of Preoperative Use of Biologic Agents on Operative Outcomes in Crohn's Disease Patients. The American surgeon, 2018 Sep 1;84(9):1526-1530 | 2018 |
| Shouval DS, Konnikova L, Griffith AE, Wall SM, Biswas A, Werner L, Nunberg M, Kammermeier J, Goettel JA, Anand R, Chen H, Weiss B, Li J, Loizides A, Yerushalmi B, Yanagi T, Beier R, Conklin LS, Ebens CL, Santos FGMS, Sherlock M, Goldsmith JD, Kotlarz D, Glover SC, Shah N, Bousvaros A, Uhlig HH, Muise AM, Klein C, Snapper SB, Enhanced TH17 Responses in Patients with IL10 Receptor Deficiency and Infantile-onset IBD. Inflammatory bowel diseases, 2017 Nov;23(11):1950-1961 | 2017 |
| Westerveld D, Li J, Glover S, Oesophageal mastocytosis: eosinophilic oesophagitis without eosinophils? BMJ case reports, 2017 Aug 28;2017 | 2017 |
| Westerveld D, Grajo J, Beattie L, Glover S, Vedolizumab: a novel medical intervention in the treatment of primary sclerosing cholangitis. BMJ case reports, 2017 May 13;2017 | 2017 |
| Unnikrishnan A, Glover SC, Norkina O, Wingard JR, Norkin M, Complete resolution of severe ulcerative colitis after haploidentical hematopoietic stem cell transplantation followed by post-transplant high-dose cyclophosphamide. Bone marrow transplantation, 2017 Aug;52(8):1204-1205 | 2017 |
| Li J, Doty AL, Tang Y, Berrie D, Iqbal A, Tan SA, Clare-Salzler MJ, Wallet SM, Glover SC, Enrichment of IL-17A+ IFN-γ+ and IL-22+ IFN-γ+ T cell subsets is associated with reduction of NKp44+ ILC3s in the terminal ileum of Crohn's disease patients. Clinical and experimental immunology, 2017 Oct;190(1):143-153 | 2017 |
| Li J, Shouval DS, Doty AL, Snapper SB, Glover SC, Erratum to: Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal Healing. Journal of clinical immunology, 2017 Feb;37(2):108 | 2017 |
| Lyons JJ, Yu X, Hughes JD, Le QT, Jamil A, Bai Y, Ho N, Zhao M, Liu Y, O'Connell MP, Trivedi NN, Nelson C, DiMaggio T, Jones N, Matthews H, Lewis KL, Oler AJ, Carlson RJ, Arkwright PD, Hong C, Agama S, Wilson TM, Tucker S, Zhang Y, McElwee JJ, Pao M, Glover SC, Rothenberg ME, Hohman RJ, Stone KD, Caughey GH, Heller T, Metcalfe DD, Biesecker LG, Schwartz LB, Milner JD, Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number. Nature genetics, 2016 Dec;48(12):1564-1569 | 2016 |
| Shouval DS, Biswas A, Kang YH, Griffith AE, Konnikova L, Mascanfroni ID, Redhu NS, Frei SM, Field M, Doty AL, Goldsmith JD, Bhan AK, Loizides A, Weiss B, Yerushalmi B, Yanagi T, Lui X, Quintana FJ, Muise AM, Klein C, Horwitz BH, Glover SC, Bousvaros A, Snapper SB, Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency. Gastroenterology, 2016 Dec;151(6):1100-1104 | 2016 |
| Nathoo S, Hood WA, Keihanian S, Collinsworth AL, Glover SC, Tofacitinib for the treatment of tumor necrosis factor-α inhibitor refractory esophageal Crohn's disease: a case report. Journal of medical case reports, 2016 Sep 23;10(1):264 | 2016 |
| Westerveld D, Patel A, Drane W, Glover S, Coming full circle: an impressive case of Crohn's disease. BMJ case reports, 2016 Feb 17;2016 | 2016 |
| Li J, Bharadwaj SS, Guzman G, Vishnubhotla R, Glover SC, ROCK I Has More Accurate Prognostic Value than MET in Predicting Patient Survival in Colorectal Cancer. Anticancer research, 2015 Jun;35(6):3267-73 | 2015 |
| Coman RM, Glover SC, Gjymishka A, Febrile pleuropericarditis, a potentially life-threatening adverse event of balsalazide--case report and literature review of the side effects of 5-aminosalicylates. Expert review of clinical immunology, 2014 May;10(5):667-75 | 2014 |
| Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, Lukas M, Fedorak RN, Lee S, Bressler B, Fox I, Rosario M, Sankoh S, Xu J, Stephens K, Milch C, Parikh A, GEMINI 2 Study Group., Vedolizumab as induction and maintenance therapy for Crohn's disease. The New England journal of medicine, 2013 Aug 22;369(8):711-21 | 2013 |
| Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, Van Assche G, Axler J, Kim HJ, Danese S, Fox I, Milch C, Sankoh S, Wyant T, Xu J, Parikh A, GEMINI 1 Study Group., Vedolizumab as induction and maintenance therapy for ulcerative colitis. The New England journal of medicine, 2013 Aug 22;369(8):699-710 | 2013 |
| Mahadevan U, Wolf DC, Dubinsky M, Cortot A, Lee SD, Siegel CA, Ullman T, Glover S, Valentine JF, Rubin DT, Miller J, Abreu MT, Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2013 Mar;11(3):286-92; quiz e24 | 2013 |
| Rapier R, Huq J, Vishnubhotla R, Bulic M, Perrault CM, Metlushko V, Cho M, Tay RT, Glover SC, The extracellular matrix microtopography drives critical changes in cellular motility and Rho A activity in colon cancer cells. Cancer cell international, 2010 Jul 28;10:24 | 2010 |
| Vishnubhotla R, Sun S, Huq J, Bulic M, Ramesh A, Guzman G, Cho M, Glover SC, ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging. Laboratory investigation; a journal of technical methods and pathology, 2007 Nov;87(11):1149-58 | 2007 |
| Tang Y, Tan SA, Iqbal A, Li J, Glover SC, STAT3 Genotypic Variant rs744166 and Increased Tyrosine Phosphorylation of STAT3 in IL-23 Responsive Innate Lymphoid Cells during Pathogenesis of Crohn's Disease. Journal of immunology research, 2019;2019:9406146 | |
| Zhang D, Glover SC, Liu W, Liu X, Lai J, Small Bowel Pyogenic Granuloma With Cytomegalovirus Infection in a Patient With Crohn's Disease (Report of a Case and Review of the Literature). In vivo (Athens, Greece), 2019 Jan-Feb;33(1):251-254 | |
| Stoner PL, Kamel A, Ayoub F, Tan S, Iqbal A, Glover SC, Zimmermann EM, Perioperative Care of Patients with Inflammatory Bowel Disease: Focus on Nutritional Support. Gastroenterology research and practice, 2018;2018:7890161 | |
| Stewart DC, Berrie D, Li J, Liu X, Rickerson C, Mkoji D, Iqbal A, Tan S, Doty AL, Glover SC, Simmons CS, Quantitative assessment of intestinal stiffness and associations with fibrosis in human inflammatory bowel disease. PloS one, 2018;13(7):e0200377 | |
| Graves CL, Li J, LaPato M, Shapiro MR, Glover SC, Wallet MA, Wallet SM, Intestinal Epithelial Cell Regulation of Adaptive Immune Dysfunction in Human Type 1 Diabetes. Frontiers in immunology, 2016;7:679 | |
| Li J, Doty AL, Iqbal A, Glover SC, The differential frequency of Lineage(-)CRTH2(-)CD45(+)NKp44(-)CD117(-)CD127(+)ILC subset in the inflamed terminal ileum of patients with Crohn's disease. Cellular immunology, 2016 Jun-Jul;304-305:63-8 | |
| Li J, Doty A, Glover SC, Aryl hydrocarbon receptor signaling involves in the human intestinal ILC3/ILC1 conversion in the inflamed terminal ileum of Crohn's disease patients. Inflammation and cell signaling, 2016;3(3) | |
| Yu HJ, Serebryannyy LA, Fry M, Greene M, Chernaya O, Hu WY, Chew TL, Mahmud N, Kadkol SS, Glover S, Prins G, Strakova Z, de Lanerolle P, Tumor stiffness is unrelated to myosin light chain phosphorylation in cancer cells. PloS one, 2013;8(11):e79776 | |
| Newsome RC, Gauthier J, Hernandez MC, Abraham GE, Robinson TO, Williams HB, Sloan M, Owings A, Laird H, Christian T, Pride Y, Wilson KJ, Hasan M, Parker A, Senitko M, Glover SC, Gharaibeh RZ, Jobin C, The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort. Gut microbes, 2021 Jan-Dec;13(1):1-15 | |